Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum
NCT01761123
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Influenza
Interventions
BIOLOGICAL:
VXA-A1.1
Sponsor
Vaxart